Author

Alfredo J. Lucendo

BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS
BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS

Alfredo J. Lucendo  et al.

BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS
BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS

Mistakes in eosinophilic oesophagitis and how to avoid them
Mistakes in eosinophilic oesophagitis and how to avoid them

Alfredo J. Lucendo  et al.

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

What happens if first-line treatment of EoE fails?
What happens if first-line treatment of EoE fails?

Alfredo J. Lucendo

TOLERANCE TO STERILIZED COW’S MILK IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS TRIGGERED BY MILK
TOLERANCE TO STERILIZED COW’S MILK IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS TRIGGERED BY MILK

Alfredo J. Lucendo  et al.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults

Alfredo J. Lucendo  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Alfredo J. Lucendo  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Alfredo J. Lucendo  et al.

DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE
DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, AND ENDOSCOPIC ASPECTS OF EOE, REGARDLESS OF PRIOR SWALLOWED TOPICAL STEROID USE

Alfredo J. Lucendo  et al.

IS THE WITHDRAWAL OF ANTI-TUMOUR NECROSIS FACTOR IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION FEASIBLE WITHOUT INCREASING THE RISK OF RELAPSE? RESULTS FROM THE RANDOMISED CLINICAL TRIAL OF GETECCU (EXIT)
IS THE WITHDRAWAL OF ANTI-TUMOUR NECROSIS FACTOR IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION FEASIBLE WITHOUT INCREASING THE RISK OF RELAPSE? RESULTS FROM THE RANDOMISED CLINICAL TRIAL OF GETECCU (EXIT)

Alfredo J. Lucendo  et al.

EFFICACY OF DUPILUMAB IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AND PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY EOE TREET STUDY
EFFICACY OF DUPILUMAB IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AND PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY EOE TREET STUDY

Alfredo J. Lucendo  et al.

EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Alfredo J. Lucendo  et al.

USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY
USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY

Alfredo J. Lucendo  et al.

IMPACT OF EPITHELIAL LYMPHOGRAM BY FLOW CYTOMETRY IN THE MANAGEMENT OF PREVIOUS INCONCLUSIVE DIAGNOSES OF CELIAC DISEASE
IMPACT OF EPITHELIAL LYMPHOGRAM BY FLOW CYTOMETRY IN THE MANAGEMENT OF PREVIOUS INCONCLUSIVE DIAGNOSES OF CELIAC DISEASE

Alfredo J. Lucendo  et al.

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

Alfredo J. Lucendo  et al.

DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY
DUPILUMAB EFFICACY AND SAFETY IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PART A OF A RANDOMIZED, PLACEBO-CONTROLLED THREE-PART, PHASE 3 STUDY

Alfredo J. Lucendo  et al.

EFFECTIVENESS OF FIRST-LINE H. PYLORI ERADICATION THERAPY ACCORDING TO THE DAILY STATIN-USE: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF FIRST-LINE H. PYLORI ERADICATION THERAPY ACCORDING TO THE DAILY STATIN-USE: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Alfredo J. Lucendo  et al.

CHANGES IN OESOPHAGEAL MICROBIOME IN EOSINOPHILIC OESOPHAGITIS BEFORE AND AFTER DIFFERENT THERAPY OPTIONS
CHANGES IN OESOPHAGEAL MICROBIOME IN EOSINOPHILIC OESOPHAGITIS BEFORE AND AFTER DIFFERENT THERAPY OPTIONS

Alfredo J. Lucendo  et al.

DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY
DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY

Alfredo J. Lucendo  et al.

Item 1 - 20 / 68
1
2 3 4